Genc Hakan, Saracoglu Meryem, Nacir Baris, Erdem Hatice Rana, Kacar Mahmut
2nd Department of Physical Medicine and Rehabilitation, Ankara Education and Research Hospital, Ministry of Health, 06340 Cebeci, Ankara, Turkey.
Joint Bone Spine. 2005 Jan;72(1):61-5. doi: 10.1016/j.jbspin.2004.03.006.
To evaluate the long-term efficacy of steroid injection for plantar fasciitis using clinical parameters and high-resolution ultrasonography.
Thirty patients (27 female and three male) with plantar fasciitis and 30 healthy controls matched by age, gender and body mass index (BMI), were enrolled in this study. Seventeen of the patients had bilateral and 13 had unilateral (six right, seven left) plantar fasciitis. Palpation-guided steroid injection was applied to the 47 heels of 30 plantar fasciitis patients. Ultrasound examination and pain intensity with visual analog scale (VAS) were assessed three times in each plantar fasciitis patients; before injection and at 1 and 6 months after steroid injection. Ultrasonography was performed to the controls at initial assessment.
The plantar fascia was remarkably thicker in the plantar fasciitis group than in controls (P < 0.001). The thickness of the plantar fascia and mean VAS values in the plantar fasciitis group decreased significantly 1 month after steroid injection (P < 0.001, P < 0.001, respectively) and a further decrease was noted 6 months postinjection (P < 0.001, P < 0.001, respectively). Strong correlation was found between the changes of plantar fascia thickness and VAS values 1 month after (P < 0.001, r: 0.61) and 6 months after (P < 0.001, r: 0.49) steroid injection. The incidence of hypoechoic fascia was 73% in the plantar fasciitis group before steroid injection. It decreased significantly at 1 and 6 months postinjection (33% and 7%, respectively, P < 0.001). Gross fascia disruption or other side effects were not observed after steroid injection.
Steroid injection could be used in plantar fasciitis treatment for its positive long-term effects.
运用临床参数和高分辨率超声评估类固醇注射治疗足底筋膜炎的长期疗效。
本研究纳入了30例足底筋膜炎患者(27例女性,3例男性)以及30名年龄、性别和体重指数(BMI)相匹配的健康对照者。其中17例患者为双侧足底筋膜炎,13例为单侧(右侧6例,左侧7例)足底筋膜炎。对30例足底筋膜炎患者的47只足跟进行触诊引导下的类固醇注射。对每位足底筋膜炎患者进行三次超声检查和视觉模拟量表(VAS)疼痛强度评估;分别在注射前、注射类固醇后1个月和6个月进行。在初始评估时对对照者进行超声检查。
足底筋膜炎组的足底筋膜明显比对照组厚(P < 0.001)。足底筋膜炎组在注射类固醇后1个月,足底筋膜厚度和平均VAS值显著降低(分别为P < 0.001,P < 0.001),注射后6个月进一步降低(分别为P <